Family history ofcolorectal cancer is a risk factor for sporadic colorectal cancer, but it is not known which step of the adenomacarcinoma pathway it influences. This case control study investigated the relation between family history of cancer and colorectal adenomas and cancers. Family history of colorectal cancer (FHCRC) was as frequent in small (<10 mm) adenoma patients (11.7%, n=154) as in polyp free patients (10.6%, n=426), whereas it was more frequent in patients with large adenoma(s) (18.8%, n=208; p<0.01 (Gut 1995; 37: 830-834) 
patients (10.6%, n=426), whereas it was more frequent in patients with large adenoma(s) ( cancers have not yet been discovered. These cancers are considered to be in most cases the result of a multistep process, adenoma formation, adenoma growth, and malignant transformation. A pedigree analysis in Utah suggested that common adenomas are inherited and that a partly penetrant autosomal dominant gene would explain the familial occurrence.5 6 To date, it is not known precisely which step(s) of the adenoma-carcinoma sequence are influenced by a family history of cancer. Therefore, we studied the family history of cancers in first degree relatives of subjects with small adenomas (< 10 mm in diameter), large adenomas, or cancers of the large bowel, and in population based, as well as in polyp free, controls.
Patients and methods A case control study was set up in the C6te d'Or area (Burgundy, France), to investigate environmental and familial risk factors in relation to the colorectal adenoma-carcinoma sequence. Details of the study population and design have been presented elsewhere.7 Briefly, patients eligible for the study were residents of the C6te d'Or area, aged 30 to 79. Exclusion criteria were familial polyposis coli, hereditary non-polyposis colorectal cancer or an inflammatory bowel disease. The groups were similar regarding education standard. As for symptoms that lead to endoscopy, for the adenoma and polyp free groups, the small adenoma and the polyp free groups were comparable in terms of the most severe symptoms that led to colonoscopy; rectal bleeding was a more common symptom in the large adenoma groups (53 44%) than in the other endoscopy groups (small polyp group: 26.0%, polyp free group: 22/8%). In this area, endoscopy is a widely available procedure and gastroenterologists are directly paid by the 'Securite Sociale' (the French national health service). Recruitment for endoscopy was independent of the familial history of cancer, as there is no consensus on the influence of such a history on the risk of colorectal tumours. Colonoscopy had to have at least reached the junction between the sigmoid and the descending colon; in most cases, when it was incomplete, it was completed by a double contrast barium enema. Colonoscopy reached the hepatic flexure at least, in 64-4%, 66-2%, and 60/8% of the large adenoma, small adenoma, and polyp free groups, respectively.
In the adenoma groups, the number of adenomas that had been removed was recorded, as well as the degree of dysplasia using the WHO classification.8 Histopathological diagnoses were performed in two laboratories centralising all pathological examinations in the area. Previous collaborative work had ensured a good consensus on the pathological features of colorectal tumours. The presence of a villous component in at least one of the polyps removed was seen in 6-5% of the small adenoma patients and 39.0% of the large adenoma patients. The highest degree of dysplasia among the resected adenomas was mild in 760%, moderate in 23.4%, and severe in 06% for the small adenoma group. Corresponding values were 32.7%, 59.1%, and 8.2% in the large adenoma group.
All subjects were interviewed at home about It can be estimated from regression models, as AR= 1 -X pj/Rj where pj is the proportion of cases in the j stratum and Rj the relative risk estimate for the corresponding stratum. In the case of a saturated model with several factors, such as, in this study, the model for studying the combined effect of alcohol and tobacco, the summary attributable risk AR is calculated from (1-AR)=(1-AR1)X(1-AR2). Calculations were performed using BMDP 4F and LR software programs. 10
Results
Family history of cancer and risk of colorectal adenomas Table II gives the frequency of a family history of cancer in each group. The frequency of a positive FHCRC was close to 11% both in the small adenoma group and in the polyp free group whereas it was 18.8% in the large adenoma group (p<001). There was no significant difference between the three groups regarding FHOC, or family history of multiple cancers.
Age did not modify the frequency of FHCRC in any group. In large adenoma patients it was 17.7% before the age of 60 (n=79) and 19.4% thereafter (n= 129). FHCRC tended to be more common in the case of moderately or severely dysplastic adenomas (18.1%, n=177) than in the case of adenomas with only mild dysplasia (13.5%, n= 185). Likewise, it was more common when there were at least two adenomas (19.9%, n= 146) than when there was only one adenoma (13.0%, n=216). It was also more frequent in case of a purely villous adenoma (23-10%, n= 13) than in the case of a tubulovillous (15.6%, n=77) or tubulous adenoma (15.4%, n=272). The differences were not statistically significant, however. Small nonsignificant differences were seen according to the degree of completion of the colonoscopy.
FHCRC was seen in 10.8 and 10.2% respectively of the polyp free controls whether or not they reached the hepatic flexure. 
Discussion
This study brought out two important aspects. The risk of colorectal cancer in subjects with FHCRC was doubled, as was the risk of large adenomas, whereas the risk of small adenomas was not affected. Subjects with a family history of any type of cancer seemed to run the risk of colorectal cancer but not of adenomas. Possible limitations of our findings must be discussed. These include the discussion of the chosen cut off point for adenoma size, risk of misclassification because of incomplete colonoscopy, and mainly potential selection and recall bias. The 1 cm cut off point was chosen as it is currently used in analytical studies on adenomas, and corresponds to a true difference in the risk of recurrence and of malignancy.'1 The relatively high rate of incomplete colonoscopies could result in misclassification of some patients considered as polyp free or with only small adenomas. However, misclassification of cases, unrelated to the variable of interest, results in reducing the effects observed towards absence of effect; the relative risks we saw can therefore be considered minimal estimates. The choice of the control group is another important issue in case control studies. This study was designed as two parallel case control studies to limit selection biases. A community based control group was felt to be the best choice to compare with the cancer group, as it was a random sample of all colorectal cancers arising in the area, recruited with the help of a well established registry of digestive tumours. As for the adenoma patients, it was necessary to compare them to polyp free patients recruited figure. The main difference in the studies available resides in the prevalence of FHCRC in the control groups. All studies with an estimated relative risk of 2, like ours, describe a prevalence of between 5 and 10%, whereas those describing a higher relative risk'5 16 have a low prevalence of FHCRC, 200% and 3°% respectively. Considering that cumulative risks of colorectal cancer range from 3 to 5°/O in Western countries, a minimal prevalence of 6% can be expected for FHCRC. Therefore, a twofold risk of colorectal cancer in the case of FHCRC is probably close to reality.
The most original aspect of this study was the high prevalence of FHCRC in patients with large adenomas, but not in those with small adenomas only. Three other studies12- '4 have shown a high frequency of FHCRC in patients with adenomas. They did not attempt to differentiate between small and large adenomas, however, although there is much evidence to suggest that they exhibit dramatically different risks of subsequent colorectal cancer.1 18 19 One explanation for familial clustering of colorectal adenomas could be common environmental factors. Little is known, however, about risk factors specific to large adenomas, and in a previous study, we found only alcohol to be a risk factor for large adenomas.7 It is often hypothesised that the genetic predisposition to cancer could act at the step of adenoma formation.5 6 Our data, dealing for the first time with this question, suggest that the genetic background to colorectal adenomas does not influence the first, but the second step of the adenoma-carcinoma pathway -that is, adenoma growth. A link between the genetic background and large adenomas could be proposed through liver metabolism. Indeed, there is experimental and epidemiological evidence to suggest that bile acids play an important part in adenoma growth.20 Recently published data suggest an interaction between a genetic factor and the bile acids profile. Patients with familial polyposis coli, but also patients with sporadic colorectal cancer, differed from controls in the composition of their biliary bile.21 22 Another aspect of differences in liver metabolism between colorectal cancer cases and controls is a higher proportion of cases with a fast acetylator status.23 It can be suggested that subjects with this genetic predisposition to colorectal tumours are more sensitive to dietary factors. There is some evidence that the genetic predisposition to colorectal cancer could be transmitted as a low penetrance autosomal dominant trait.5 6 This low penetrance could be explained by a certain proportion of the people prone to colorectal cancer who are not exposed to the aforementioned dietary risk factors.
The second important finding was that a family history of cancer, whatever the type, increased the risk of colorectal cancer but not of colorectal adenomas. Common environmental factors are less likely for cancers of various types than for familial clustering of colorectal cancers. This suggests the existence of a gene or several genes that control for the risk of malignant changes, and are not specific of a particular type of cancer. Such genes, which control for DNA mismatch repair, have recently been described on chromosomes 2 and 3,23 and involved in hereditary nonpolyposis colorectal cancer syndrome, which is characterised by an increased risk of several types of cancer. Replication errors (RER+ phenotype) have also been identified in cells of sporadic colorectal cancers.24 25 but not in adenomas.25 Genetic abnormality of this kind would increase the sensitivity to mutagens of actively dividing cells, such as those of promoted adenomas.
In conclusion, this study shows for the first time that two familial risk factors could independently increase the risk of colorectal cancer, one acting at the level of adenoma growth and specifically related to colorectal tumours, and a non-specific factor, which would increase the risk of malignant changes. Patients with both a large adenoma and a family history of cancer are at high risk of colorectal cancer and should be considered as a priority group for prevention studies.
